MMACHC and cerebral palsy: In this case, clinical manifestations include cerebral palsy, developmental delay, epilepsy, hypertension, proteinuria, chronic renal insufficiency; laboratory findings showed elevated methylmalonic acid-2, acetyl carnitine, propionyl carnitine in blood and urine; genetic testing revealed a compound heterozygous mutation in MMACHC gene [c.